Platelet-Neutrophil Association in NETs-Rich Areas in the Retrieved AIS Patient Thrombi.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
21 Nov 2022
Historique:
received: 04 10 2022
revised: 08 11 2022
accepted: 10 11 2022
entrez: 26 11 2022
pubmed: 27 11 2022
medline: 30 11 2022
Statut: epublish

Résumé

Histological structure of thrombi is a strong determinant of the outcome of vascular recanalization therapy, the only treatment option for acute ischemic stroke (AIS) patients. A total of 21 AIS patients from this study after undergoing non-enhanced CT scan and multimodal MRI were treated with mechanical stent-based and manual aspiration thrombectomy, and thromboembolic retrieved from a cerebral artery. Complementary histopathological and imaging analyses were performed to understand their composition with a specific focus on fibrin, von Willebrand factor, and neutrophil extracellular traps (NETs). Though distinct RBC-rich and platelet-rich areas were found, AIS patient thrombi were overwhelmingly platelet-rich, with 90% of thrombi containing <40% total RBC-rich contents (1.5 to 37%). Structurally, RBC-rich areas were simple, consisting of tightly packed RBCs in thin fibrin meshwork with sparsely populated nucleated cells and lacked any substantial von Willebrand factor (VWF). Platelet-rich areas were structurally more complex with thick fibrin meshwork associated with VWF. Plenty of leukocytes populated the platelet-rich areas, particularly in the periphery and border areas between platelet-rich and RBC-rich areas. Platelet-rich areas showed abundant activated neutrophils (myeloperoxidase+ and neutrophil-elastase+) containing citrullinated histone-decorated DNA. Citrullinated histone-decorated DNA also accumulated extracellularly, pointing to NETosis by the activated neutrophils. Notably, NETs-containing areas showed strong reactivity to VWF, platelets, and high-mobility group box 1 (HMGB1), signifying a close interplay between these components.

Identifiants

pubmed: 36430952
pii: ijms232214477
doi: 10.3390/ijms232214477
pmc: PMC9694992
pii:
doi:

Substances chimiques

von Willebrand Factor 0
Histones 0
Fibrin 9001-31-4
DNA 9007-49-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council (MRC) Hamad Medical Corporation (HMC) Doha, Qatar
ID : IRGC-02-SI-029

Références

J Exp Med. 2012 Apr 9;209(4):819-35
pubmed: 22451716
J Clin Invest. 2015 Dec;125(12):4638-54
pubmed: 26551681
Thromb Haemost. 1999 Mar;81(3):400-6
pubmed: 10102469
J Clin Invest. 2000 Mar;105(6):783-91
pubmed: 10727447
Arterioscler Thromb Vasc Biol. 2000 Jun;20(6):1661-7
pubmed: 10845886
Clin Rev Allergy Immunol. 2021 Oct;61(2):194-211
pubmed: 32740860
Thromb Haemost. 2001 Jul;86(1):189-97
pubmed: 11487007
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
Blood. 2013 Jun 20;121(25):5088-97
pubmed: 23589671
Lancet. 2018 Nov 10;392(10159):1736-1788
pubmed: 30496103
J Exp Med. 2006 Mar 20;203(3):767-76
pubmed: 16533881
Science. 1980 Feb 1;207(4430):541-3
pubmed: 7352265
Circulation. 2001 Dec 4;104(23):2855-64
pubmed: 11733407
Curr Opin Hematol. 2003 Mar;10(2):142-9
pubmed: 12579041
Blood. 2014 May 1;123(18):2768-76
pubmed: 24366358
PLoS Pathog. 2009 Oct;5(10):e1000639
pubmed: 19876394
Nat Rev Microbiol. 2007 Aug;5(8):577-82
pubmed: 17632569
Blood. 2009 Nov 26;114(23):4883-5
pubmed: 19726719
Platelets. 2021 Apr 3;32(3):314-324
pubmed: 32896192
J Neuroradiol. 2015 Apr;42(2):86-92
pubmed: 24560545
J Biol Chem. 2001 Nov 2;276(44):41059-63
pubmed: 11557746
Nat Med. 2008 Sep;14(9):949-53
pubmed: 18690244
Annu Rev Fluid Mech. 2015 Jan 1;47:377-403
pubmed: 26236058
Neurology. 2015 Feb 10;84(6):623-5
pubmed: 25666629
Stroke. 2006 Aug;37(8):2086-93
pubmed: 16794209
Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1382-9
pubmed: 24790143
FASEB J. 2003 Aug;17(11):1490-2
pubmed: 12824298
J Thromb Haemost. 2016 May;14(5):918-30
pubmed: 26929147
Ann N Y Acad Sci. 1992 Dec 4;667:70-80
pubmed: 1285024
Thromb Haemost. 2008 Feb;99(2):343-51
pubmed: 18278184
J Clin Invest. 2022 May 16;132(10):
pubmed: 35358095
Curr Biol. 2006 Feb 21;16(4):396-400
pubmed: 16488874
Front Immunol. 2016 Jul 06;7:271
pubmed: 27458459
J Thromb Haemost. 2014 Dec;12(12):2074-88
pubmed: 25163512
Curr Opin Microbiol. 2007 Feb;10(1):52-6
pubmed: 17208512
Blood. 1998 Jun 15;91(12):4397-418
pubmed: 9616133
PLoS One. 2014 Feb 11;9(2):e88882
pubmed: 24523944
Thromb Res. 2007;120 Suppl 1:S5-9
pubmed: 17493665
Stroke. 2016 Jul;47(7):1864-71
pubmed: 27197854
Exp Transl Stroke Med. 2015 Jan 27;7:2
pubmed: 25657829
Blood. 2016 May 12;127(19):2337-45
pubmed: 26929275
Circulation. 1989 Apr;79(4):920-8
pubmed: 2494006
AJNR Am J Neuroradiol. 2015 Sep;36(9):1756-62
pubmed: 26159515
Sci Rep. 2018 Feb 1;8(1):2068
pubmed: 29391442
Haematologica. 2020 Jan 31;105(2):498-507
pubmed: 31048352
Cell. 1998 Sep 4;94(5):657-66
pubmed: 9741630
Stroke. 2018 Mar;49(3):754-757
pubmed: 29438080
J Am Heart Assoc. 2020 Aug 4;9(15):e016534
pubmed: 32750304
Ann Neurol. 2017 Aug;82(2):223-232
pubmed: 28696508
Science. 2004 Mar 5;303(5663):1532-5
pubmed: 15001782
Clin Neuroradiol. 2016 Jun;26(2):189-97
pubmed: 25261075
Cardiovasc Hematol Disord Drug Targets. 2009 Mar;9(1):9-20
pubmed: 19275573
Neurology. 2018 Jun 5;90(23):1075
pubmed: 29866933
Stroke. 2011 May;42(5):1237-43
pubmed: 21393591
Blood. 2017 Oct 19;130(16):1795-1799
pubmed: 28811305
Atherosclerosis. 2014 May;234(1):102-7
pubmed: 24632509
Cell Death Discov. 2018 Jun 28;4:6
pubmed: 30062055
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2415-9
pubmed: 12606706
Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):728-39
pubmed: 17272754
Blood. 2012 Sep 6;120(10):2133-43
pubmed: 22837532
Nature. 2001 Oct 4;413(6855):488-94
pubmed: 11586351
Nat Med. 2007 Apr;13(4):463-9
pubmed: 17384648
Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2261-9
pubmed: 21799176
Ann N Y Acad Sci. 2013 Apr;1281:51-63
pubmed: 23317344
Blood. 2008 Mar 15;111(6):3070-80
pubmed: 18182576
Curr Opin Hematol. 2007 May;14(3):236-41
pubmed: 17414213
Blood. 2006 Mar 1;107(5):1943-50
pubmed: 16293606
Blood. 2014 May 22;123(21):3354-63
pubmed: 24553181
Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1777-83
pubmed: 22652600
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
Int J Mol Sci. 2022 Jan 26;23(3):
pubmed: 35163333
J Innate Immun. 2009;1(3):176-80
pubmed: 20375575
JAMA Neurol. 2015 Aug;72(8):928-34
pubmed: 26030910
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15880-5
pubmed: 20798043
Cerebrovasc Dis. 2014;37(2):116-22
pubmed: 24435107
Stroke. 2012 Feb;43(2):599-606
pubmed: 22180250
Proc Natl Acad Sci U S A. 2006 Nov 7;103(45):16900-5
pubmed: 17075060
J Biol Chem. 2013 Mar 8;288(10):6946-56
pubmed: 23293023
Nat Rev Neurol. 2014 Mar;10(3):135-43
pubmed: 24514866
Curr Opin Hematol. 2021 Sep 1;28(5):301-307
pubmed: 34183536

Auteurs

Ghulam Jeelani Pir (GJ)

The Neuroscience Institute and Academic Health System, Hamad Medical Corporation, Doha 3050, Qatar.

Aijaz Parray (A)

The Neuroscience Institute and Academic Health System, Hamad Medical Corporation, Doha 3050, Qatar.

Raheem Ayadathil (R)

The Neuroscience Institute and Academic Health System, Hamad Medical Corporation, Doha 3050, Qatar.

Sajitha V Pananchikkal (SV)

The Neuroscience Institute and Academic Health System, Hamad Medical Corporation, Doha 3050, Qatar.

Fayaz Ahmad Mir (FA)

Qatar Metabolic Institute, Academic Health System, Hamad Medical Corporation, Doha 3050, Qatar.

Islam Muhammad (I)

College of Medicine, Qatar University (QU) Health, Qatar University, Doha 2713, Qatar.

Ahmed Abubakar (A)

College of Medicine, Qatar University (QU) Health, Qatar University, Doha 2713, Qatar.

Nueman Amir (N)

Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Health Sciences Centre Sherbrook Street, Winnipeg, MB R3A 1R9, Canada.

Sohail Hussain (S)

The Neuroscience Institute and Academic Health System, Hamad Medical Corporation, Doha 3050, Qatar.

Khawaja H Haroon (KH)

The Neuroscience Institute and Academic Health System, Hamad Medical Corporation, Doha 3050, Qatar.

Ahmad Muhammad (A)

The Neuroscience Institute and Academic Health System, Hamad Medical Corporation, Doha 3050, Qatar.

Yahya Imam (Y)

The Neuroscience Institute and Academic Health System, Hamad Medical Corporation, Doha 3050, Qatar.

Satya Narayana Patro (SN)

Department of Radiology, UAMS Medical Center, 4301 W. Markham St., Little Rock, AR 72205, USA.

Naveed Akhtar (N)

The Neuroscience Institute and Academic Health System, Hamad Medical Corporation, Doha 3050, Qatar.

Aymen Zakaria (A)

The Neuroscience Institute and Academic Health System, Hamad Medical Corporation, Doha 3050, Qatar.

Saadat Kamran (S)

The Neuroscience Institute and Academic Health System, Hamad Medical Corporation, Doha 3050, Qatar.
Weill Cornell Medical School, Doha 24144, Qatar.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH